fashion -WSS

fashion

author：comprehensive 2025-09-07 06:41:26 - browse：55

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans.

The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel starting Tuesday to discuss how to best evaluate safety and effectiveness, as well as the ethical quandaries in running clinical trials. The second day will be closed to the public to shield trade secrets.

Several research teams are racing to build artificial placentas that replicate the uterine environment and give the very prematurely born a better shot at survival. A team at the Children’s Hospital of Philadelphia, led by Alan Flake, is the closest to human trials — their device is a bag filled with sterile fluid, which contains the fetus and is connected to tubes providing oxygen and nutrition.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Updated Covid vaccine has 54% effectiveness, new study suggests

WSS

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

What’s missing from the debate over nursing home staff minimums

Global cancer cases to surge 77% by 2050, WHO report says

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Hospitals owned by private equity see complications spike 25%

Prime Medicine, Myeloid Therapeutics clash over genome

focus

fashion

focus

The cancer drug shortage isn’t new — and neither are the solutions

Why health records don't always know when patients are dead

Anesthesiologist group: stop taking Ozempic before surgery

SEC charges former device maker CEO with $41 million fraud

The cancer drug shortage isn’t new — and neither are the solutions

The CDC's new social media misinformation war

New air purifier tech could be key to improving indoor air quality

Christmas in the PICU brings some surprising joy

Medicare proposal to cover medical devices draws a mixed reaction

Violet CEO on training clinicians to promote more inclusive care

Wikipedia

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Readout LOUD: Venture capital, Gilead, and more M&A

The CDC's new social media misinformation war

CRISPR gene editing developments we’re watching in 2024

David Ricks of Eli Lilly: best biopharma CEO of 2023

SNAP should offer more nutrition education

focus

Wikipedia

Wikipedia

leisure time